14/05/2019 : Theradiag strengthens its presence in the United States on biotherapy monitoring

Croissy-Beaubourg, May 14, 2019, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, is today announcing plans to accelerate its development in the United States, the world’s largest…

Continue Reading 14/05/2019 : Theradiag strengthens its presence in the United States on biotherapy monitoring